Last reviewed: July 1, 2026
Last updated: July 1, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide, the active ingredient in Ozempic, reduces appetite by mimicking a natural hormone that regulates blood sugar and hunger signals. Originally developed for diabetes management, this medication has gained attention for weight loss, but using a diabetes drug off-label comes with important considerations about cost, supply, side effects, and whether it matches your individual biology.
How Semaglutide Works for Weight Loss
Semaglutide activates GLP-1 receptors in the brain and gut, signaling fullness and reducing food cravings within 30 minutes to 2 hours of injection. This mechanism slows stomach emptying, meaning food stays in your digestive system longer and you feel satisfied on smaller portions. Clinical trials show users lose an average of 15% of body weight over 68 weeks when combined with lifestyle changes.
The medication works best for people whose hunger and appetite control are driven by GLP-1 pathway activity. However, genetic variation affects how well GLP-1 receptors function—some people respond powerfully to semaglutide while others see modest results. This is why personalized approaches matter; not everyone's weight challenge stems from the same biological mechanism.
Ozempic Supply Shortages and Access Issues
Since 2022, demand for semaglutide has far exceeded supply, particularly as celebrities and social media amplified its weight-loss use. Ozempic prescriptions prioritize diabetic patients, leaving weight-loss seekers on waitlists or paying premium prices through specialty pharmacies. This scarcity has driven costs above $900 per month for brand-name versions and created uncertainty around consistent access.
PlexusDx offers compounded semaglutide injection from licensed 503A compounding pharmacies starting at $149 per month, with no insurance required and availability across all 50 states. Unlike brand-name products affected by supply disruptions, compounded semaglutide provides a stable alternative that works through the same mechanism but remains accessible when commercial supplies tighten.
Common Side Effects and Long-Term Tolerability
Nausea, vomiting, constipation, and diarrhea occur in 25–50% of users during dose escalation, typically subsiding after 4–8 weeks as the body adapts. Less common but serious concerns include pancreatitis risk, potential thyroid effects (mainly in patients with personal or family history), and dehydration from reduced food intake. Muscle loss can accompany weight loss if protein intake and exercise are not prioritized.
Long-term safety data beyond 2 years remains limited for weight loss. Studies show most people regain weight after stopping semaglutide, suggesting it requires ongoing use. Additionally, the high cost and side-effect profile mean semaglutide is not ideal for everyone—especially those with GI sensitivity, pancreatitis history, or medullary thyroid cancer family history. This is where genetic testing and personalized protocol selection become valuable.
Personalized Alternatives: Beyond One-Size-Fits-All Semaglutide
Not every weight-loss challenge responds to GLP-1 stimulation alone. Some individuals carry genetic variants in the FTO gene (associated with increased appetite), MC4R (melanocortin signaling), or GIPR (glucose-dependent insulinotropic peptide receptor) that influence hunger differently. PlexusDx Precision Peptide Genetic Test maps 14 distinct pathways and 49 peptides to reveal which mechanisms are driving your weight plateau.
Based on genetic insights, PlexusDx offers tirzepatide (a dual GLP-1 and GIP receptor agonist) starting at $249 per month, the Microdose GLP-1 Protocol at $129 per month for those sensitive to standard doses, or GLP-Squared combinations that target multiple appetite pathways simultaneously. Your dose may need to go up. Your price won't—PlexusDx uses flat monthly pricing, not dose ladders, so cost remains predictable even as your treatment evolves.
When Ozempic or Semaglutide Makes Medical Sense
Semaglutide is most effective for individuals with BMI ≥30 (or ≥27 with weight-related conditions) who struggle with constant hunger, frequent snacking, or emotional eating. It works better in people who are physically capable of tolerating GI side effects and can commit to long-term use, dietary changes, and regular exercise. Having type 2 diabetes or prediabetes strengthens the case, since semaglutide improves both glucose control and weight simultaneously.
Conversely, semaglutide may not be the right starting point if you have a history of pancreatitis, medullary thyroid cancer, thyroid nodules, severe GI disorders, or significant muscle loss concerns. Pregnancy planning, breastfeeding, or inability to afford ongoing treatment also warrant exploring other options. PlexusDx recommends consulting with a clinician and considering genetic testing to confirm semaglutide aligns with your biology and lifestyle before committing.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is Ozempic FDA-approved for weight loss?
No. Ozempic (semaglutide) is FDA-approved only for type 2 diabetes. Wegovy, a higher-dose semaglutide product, is FDA-approved for weight management—but Ozempic prescribed off-label for weight loss is an unapproved use. PlexusDx compounded semaglutide is not FDA-approved but is compounded under 503A pharmacy standards for clinical use as prescribed.
How much weight can I expect to lose with semaglutide?
Clinical trials show average weight loss of 10–15% of body weight over 68 weeks when combined with diet and exercise. Individual results vary widely based on starting weight, adherence, lifestyle, and how well your body responds to GLP-1 activation. Genetic factors like GLP1R and GIPR variants influence individual response; PlexusDx Precision Peptide Genetic Test can reveal whether your genes suggest strong or modest GLP-1 responsiveness.
What does semaglutide cost with PlexusDx?
PlexusDx compounded semaglutide injection starts at $149 per month with flat pricing across commitment tiers. No insurance is required, and it is HSA/FSA eligible. Unlike flat per-compound pricing at other providers, your monthly cost remains stable even if your dose increases, ensuring predictable long-term affordability.
What happens if I stop taking semaglutide?
Most users regain lost weight within 1–2 years of stopping semaglutide because appetite hormones and hunger signals return to baseline. This is why semaglutide is considered a long-term maintenance medication rather than a short-term fix. To sustain results, you must continue the medication or combine it with permanent lifestyle and dietary changes that address underlying appetite biology.
How can genetic testing help me choose between semaglutide and other options?
PlexusDx Precision Peptide Genetic Test identifies variants in GLP1R, GIPR, FTO, and MC4R genes that predict how well you'll respond to GLP-1, GIP, or combined therapies. If your profile shows strong GLP1R activity, semaglutide is an excellent fit; if GIPR dominance is detected, tirzepatide may work better. Testing costs $99 after your first month of treatment and personalizes your therapy beyond guesswork.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Your Zepbound Pen: Safe Handling, Smart Disposal, and Why Tampering Is Never the Answer
Is Ozempic FDA Approved? What You Need to Know About This Popular Medication